Berger specialized in cancer long before joining Genentech, holding oncology global clinical development roles at Amgen and ...
(Reuters) -Gilead Sciences said on Thursday it has appointed Sanofi’s Dietmar Berger as its chief medical officer, replacing ...
Gilead Sciences, Inc. has announced that Dietmar Berger, MD, PhD, will join the company on January 2, 2025, as Chief Medical ...
Gilead CEO Daniel O’Day has hired Berger away from Sanofi. Elsewhere, Lonza is reorganizing and Bausch + Lomb is exploring a ...
Gilead Sciences names Sanofi's Dietmar Berger as new CMO, replacing Merdad Parsey amid challenging year marked by setbacks ...
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief ...
In the latest trading session, Altria (MO) closed at $54.92, marking a -0.13% move from the previous day. Meanwhile, the Dow lost 0.2%, and the Nasdaq, a tech-heavy index, added 0.12%. Prior to ...
Satellite images reveal Russian military equipment being prepared for loading, a possible prelude to its withdrawal from Syria. Travis Timmerman, an American who was found earlier this week, was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback